Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis. - Wikidata - awgldk - TriplyDB

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

http://www.wikidata.org/entity/Q42779710

about

Cognitive training programs for childhood cancer patients and survivors: A critical review and future directions.Incidence and relative survival of anaplastic astrocytomas.TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort.Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.Prognostic Role of microRNA-21 Expression in Brain Tumors: a Meta-analysis.Molecularly based management of gliomas in clinical practice.Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.Biomarkers and therapeutic advances in glioblastoma multiforme.Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma.The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) Resource in Neuro-Oncology.Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas.A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers.Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance.

P2860

Q34044232-57888223-68DC-427D-BB28-7A51EF54B036 Q34193735-703F7239-77A5-4B2C-B416-847B5B00E797 Q35833084-070D9C86-70E1-4CB3-BA8C-6D08B7C6454C Q36140650-9FA24DA5-E072-4880-906F-7F127C6A50CD Q36234884-F9370A0E-2DBD-4C3C-A2F7-4A20745ECA9D Q38384219-F71390C9-7EEF-4A09-8CF2-BABBBEABF819 Q38551010-81385038-80DC-4338-85FE-1641D8CCCDB6 Q38759771-568AF1C7-50F0-42E7-9E25-4B7910E6C860 Q40070524-2809473B-B581-473E-AD4F-68BBA4B6E232 Q46835405-7B70E911-3CD4-4514-8293-8BEE00DB8A46 Q47755845-B32283BA-37AC-4396-B76C-6895CBF0814E Q47830458-22A94BD2-F992-4B66-A7EA-23D319C1B377 Q48510426-667626BD-3E4D-4771-9779-C3DA739C197C Q55663256-16D1AA1B-4FEF-44FC-8F43-C891C0D25395

P2860

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

http://www.wikidata.org/entity/Q42779710

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@en

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@nl

type

label

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@en

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@nl

prefLabel

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@en

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@nl

P1433

Q42779710-EC46F2A3-A51F-44AE-BD6B-9B44F3F2EC54

P1476

Q42779710-A1DF113F-B4A6-4170-B2DD-B2CAB0ED50D1

P2093

Q42779710-125C34C2-233D-4ED4-8F0F-7372FACF6428

Q42779710-8BAAEC0F-8118-43DD-86EF-69B3B7C990B3

Q42779710-D5AAF9E7-A794-4028-A568-A4664CDB505D

P2860

Q42779710-0281B1BE-AA1F-481A-B024-DA8E5B3EB1CF

Q42779710-04F46227-A60B-4542-BD5F-3B4B9B6BA05D

Q42779710-086693B9-B771-4D00-A3CE-AD6A2F24C6F8

Q42779710-093EF255-1DD3-4381-A463-3FF1B42BA1E1

Q42779710-104729BC-DF62-4B60-937D-801317C62CD3

Q42779710-1799DAC8-59F9-475D-BEB3-709F01A3FED9

Q42779710-1E018194-4F43-44BA-BF7D-00A52E5E2EC0

Q42779710-1F6E1C0C-AADA-45FE-8073-3F82B6136270

Q42779710-208C18EF-4052-4F2A-99E7-91F3495B9300

Q42779710-230C8C2C-97DB-43EC-8C69-AD18D9C26113

P304

Q42779710-3A6D3FF1-F154-44F3-828E-C999E6AD0E75

P31

Q42779710-1B34C892-82C3-4EF7-A72D-03DBC5AFFCA6

Q42779710-5e9db124-45fb-4e8c-b7f5-eacc8c762645

P356

Q42779710-14880AD6-92B9-44B8-8223-BABEDFFA56AF

P433

Q42779710-0E94055F-FE06-4CEC-B55B-7FB9E13D666A

P478

Q42779710-7C3191A9-B2E0-4DCB-BA82-9150FD4292D5

P577

Q42779710-E4EF76C7-8323-4F9D-9634-DC7E993E7682

P698

Q42779710-0C406453-FB4B-4DC8-A839-A5F65F8FBC5C

P932

Q42779710-5E992A73-C1C0-4068-8401-2E736DD2D2DD

P356

P1433

P1476

Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.

@en

P2093

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Jiaxin Zhao

http://www.w3.org/2001/XMLSchema#string

Wenjie Ma

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

Operating characteristics of a rank correlation test for publication bias

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

Practical methods for incorporating summary time-to-event data into meta-analysis

Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.

Prognostic stratification of patients with anaplastic gliomas according to genetic profile.

P304

103-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOT145

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24311641

http://www.w3.org/2001/XMLSchema#string

P932

3870828

http://www.w3.org/2001/XMLSchema#string